Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing

被引:115
作者
Nakazawa, T
Nakajima, A
Shiomi, K
Moriya, H
Einhorn, TA
Yamazaki, M
机构
[1] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608677, Japan
[2] Daiichi Suntory Pharma Co Ltd, Inst Med Res & Dev, Gunma 3700503, Japan
[3] Boston Univ, Med Ctr, Dept Orthopaed Surg, Boston, MA 02118 USA
关键词
parathyroid hormone (PTH); low-dose; intermittent treatment; chondrogenesis; fracture healing;
D O I
10.1016/j.bone.2005.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have demonstrated that intermittent administration of parathyroid hormone (PTH) enhances osteogenesis (hard callus formation) and increases mechanical strength in experimental fracture healing. Thus far, however, effects of PTH on chondrogenesis (soft callus formation) during fracture healing have not been fully elucidated. In the present Study, we analyzed the underlying molecular mechanism by which exogenous PTH would affect chondrogenesis in a model of experimental fracture healing. Unilateral femoral fractures were produced in 2-month-old Sprague-Dawley rats. Daily subcutaneous injections of 10 mu g/kg of recombinant human PTH(1-34) [rhPTH (1-34)] were administered over a 28-day period of fracture healing. Control animals were injected with vehicle solution (normal saline) alone. The results showed that, on day 14 after fracture, cartilage area in the PTH-treated group was significantly increased (1.4-fold) compared with the controls. but this increase was not observed at days 21 and 28. fit the early stage of chondrogenesis (days 4-7), cell proliferation, expressed as the rate of proliferating cell nuclear antigen-positive cells, was increased in mesenchymal (chondroprogenitor) cells but not chondrocytes in the PTH-treated group compared with controls. In addition, gene expression of SOX-9 was Up-regulated in the PTH-treated group oil day 4 (1.4-fold), and this was accompanied by enhanced expression of pro-alpha 1 (II) collagen (1.8-fold). After 14 days, there were no significant differences between groups in either cell proliferation or the expression levels of cartilage differentiation-related genes (SOX-9, pro-alpha 1 (X) collagen, pro-alpha 1 (X) collagen and osteopontin). These results suggest that intermittent treatment with low-dose rhPTH(1-34) induces a larger cartilaginous callus but does not delay chondrocyte differentiation during fracture healing. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:711 / 719
页数:9
相关论文
共 34 条
[1]   Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34) [J].
Alkhiary, YM ;
Gerstenfeld, LC ;
Krall, E ;
Westmore, M ;
Sato, M ;
Mitlak, BH ;
Einhorn, TA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (04) :731-741
[2]   PARATHYROID HORMONE-RELATED PEPTIDE-DEPLETED MICE SHOW ABNORMAL EPIPHYSEAL CARTILAGE DEVELOPMENT ALTERED ENDOCHONDRAL BONE-FORMATION [J].
AMIZUKA, N ;
WARSHAWSKY, H ;
HENDERSON, JE ;
GOLTZMAN, D ;
KARAPLIS, AC .
JOURNAL OF CELL BIOLOGY, 1994, 126 (06) :1611-1623
[3]   Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures [J].
Andreassen, TT ;
Ejersted, C ;
Oxlund, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) :960-968
[4]   Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone [J].
Andreassen, TT ;
Fledelius, C ;
Ejersted, C ;
Oxlund, H .
ACTA ORTHOPAEDICA SCANDINAVICA, 2001, 72 (03) :304-307
[5]   SOX9 directly regulates the type-II collagen gene [J].
Bell, DM ;
Leung, KKH ;
Wheatley, SC ;
Ng, LJ ;
Zhou, S ;
Ling, KW ;
Sham, MH ;
Koopman, P ;
Tam, PPL ;
Cheah, KSE .
NATURE GENETICS, 1997, 16 (02) :174-178
[6]  
BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115
[7]   DIFFERENTIAL-EFFECTS OF PARATHYROID-HORMONE ON CHICK GROWTH PLATE AND ARTICULAR CHONDROCYTES [J].
CRABB, ID ;
OKEEFE, RJ ;
PUZAS, JE ;
ROSIER, RN .
CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) :61-66
[8]   Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study [J].
Dempster, DW ;
Cosman, F ;
Kurland, ES ;
Zhou, H ;
Nieves, J ;
Woelfert, L ;
Shane, E ;
Plavetic, K ;
Müller, R ;
Bilezikian, J ;
Lindsay, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1846-1853
[9]   A COMPARISON OF THE INVIVO BIOCHEMICAL RESPONSES TO EXOGENOUS PARATHYROID HORMONE-(1-34) [PTH-(1-34)] AND PTH-RELATED PEPTIDE-(1-34) IN MAN [J].
FRAHER, LJ ;
HODSMAN, AB ;
JONAS, K ;
SAUNDERS, D ;
ROSE, CI ;
HENDERSON, JE ;
HENDY, GN ;
GOLTZMAN, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :417-423
[10]   Parathyroid hormone-(1-34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway [J].
Harvey, AK ;
Yu, XP ;
Frolik, CA ;
Chandrasekhar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23249-23255